PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 1 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $15,998,000 | +1925.1% | 889,268 | +702.7% | 0.01% | +1000.0% |
| Q1 2020 | $790,000 | -88.9% | 110,787 | -62.7% | 0.00% | -80.0% |
| Q4 2019 | $7,088,000 | +95.4% | 296,844 | +119.5% | 0.01% | +66.7% |
| Q3 2019 | $3,627,000 | +116.5% | 135,264 | +119.1% | 0.00% | +200.0% |
| Q2 2019 | $1,675,000 | -22.1% | 61,749 | -0.3% | 0.00% | -50.0% |
| Q1 2019 | $2,151,000 | +99.9% | 61,963 | +12.4% | 0.00% | +100.0% |
| Q4 2018 | $1,076,000 | -89.2% | 55,110 | -85.2% | 0.00% | -88.9% |
| Q3 2018 | $9,933,000 | -32.7% | 373,012 | -4.6% | 0.01% | -35.7% |
| Q2 2018 | $14,765,000 | -25.2% | 390,915 | -35.3% | 0.01% | -22.2% |
| Q1 2018 | $19,737,000 | +70.5% | 604,323 | +154.1% | 0.02% | +80.0% |
| Q4 2017 | $11,579,000 | +51.6% | 237,859 | +68.3% | 0.01% | +42.9% |
| Q3 2017 | $7,639,000 | +26.0% | 141,369 | +31.0% | 0.01% | +16.7% |
| Q2 2017 | $6,063,000 | +0.2% | 107,945 | -30.1% | 0.01% | +20.0% |
| Q1 2017 | $6,051,000 | +156.1% | 154,411 | +46.6% | 0.01% | +150.0% |
| Q4 2016 | $2,363,000 | +56.7% | 105,343 | +58.6% | 0.00% | +100.0% |
| Q3 2016 | $1,508,000 | +2.2% | 66,406 | +6.2% | 0.00% | -50.0% |
| Q2 2016 | $1,476,000 | -20.1% | 62,522 | -31.0% | 0.00% | 0.0% |
| Q1 2016 | $1,848,000 | -36.4% | 90,591 | +60.5% | 0.00% | -33.3% |
| Q4 2015 | $2,904,000 | +26.7% | 56,459 | +5.0% | 0.00% | 0.0% |
| Q3 2015 | $2,292,000 | -40.9% | 53,791 | -36.8% | 0.00% | -25.0% |
| Q2 2015 | $3,875,000 | +55.6% | 85,077 | +29.7% | 0.00% | +33.3% |
| Q1 2015 | $2,490,000 | +126.0% | 65,579 | +68.7% | 0.00% | +200.0% |
| Q4 2014 | $1,102,000 | +131.5% | 38,883 | +106.8% | 0.00% | – |
| Q3 2014 | $476,000 | -62.3% | 18,802 | -56.5% | 0.00% | -100.0% |
| Q2 2014 | $1,262,000 | +196.9% | 43,245 | +163.5% | 0.00% | – |
| Q1 2014 | $425,000 | +15.8% | 16,412 | +15.1% | 0.00% | – |
| Q4 2013 | $367,000 | +65.3% | 14,255 | +71.1% | 0.00% | – |
| Q3 2013 | $222,000 | – | 8,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |